Literature DB >> 12519138

Effect of route of buprenorphine on recovery and postoperative analgesic requirement in paediatric patients.

Fauzia Anis Khan1, Ghulam Asghar Memon, Rehana S Kamal.   

Abstract

BACKGROUND: We compared the effects of extradural with intravenous (i.v.) buprenorphine on postoperative pain and recovery characteristics.
METHODS: Thirty patients, aged 11-13 years, who were undergoing inguinal hernia repair with or without orchidopexy, were randomly allocated to receive either caudal 0.5% bupivacaine alone (group A) or were additionally given i.v. buprenorphine 2.5 micro g.kg-1 (group B) or caudal buprenorphine in the same dose (group C). Patients were followed for 8 h after the end of surgery.
RESULTS: All patients remained haemodynamically stable during the study period and no clinical respiratory depression was seen. Nausea, vomiting, urinary retention and pruritus were more common in the extradural buprenorphine group. Three patients in group A, five in group B and eight in group C did not require any additional analgesia during the study period. The incidence of vomiting was 20%, 50% and 80% in groups A, B and C, respectively. Four patients in group C had urinary retention compared with one each in the other two groups.
CONCLUSIONS: Administration of buprenorphine resulted in a higher incidence of side-effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12519138     DOI: 10.1046/j.1460-9592.2002.00941.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  3 in total

Review 1.  [Buprenorphine in children. A clinical and pharmacological review].

Authors:  E Michel; B Zernikow
Journal:  Schmerz       Date:  2006-02       Impact factor: 1.107

Review 2.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

3.  Buprenorphine and pain treatment in pediatric patients: an update.

Authors:  Erendira Vicencio-Rosas; María Gabriela Pérez-Guillé; Carmen Flores-Pérez; Janett Flores-Pérez; Francisca Trujillo-Jiménez; Juan Luis Chávez-Pacheco
Journal:  J Pain Res       Date:  2018-03-15       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.